
浏览全部资源
扫码关注微信
1.河南中医药大学 第一附属医院,郑州 450011
2.河南中医药大学,郑州 450015
3.河南省中医院,郑州 450003
万红,硕士,主治医师,从事内分泌疾病的临床工作,E-mail:13837123279@163.com
燕树勋,博士,教授,从事内分泌疾病的临床工作,E-mail:ysx982001@163.com
收稿日期:2020-12-24,
网络出版日期:2021-02-04,
纸质出版日期:2021-06-20
移动端阅览
万红,闫诏,李媛媛等.加减消积保中颗粒联合刮痧治疗腹型肥胖胃热湿阻证的临床观察[J].中国实验方剂学杂志,2021,27(12):97-102.
WAN Hong,YAN Zhao,LI Yuan-yuan,et al.Clinical Efficacy of Modified Xiaoji Baozhong Granules Combined with Scraping in Treatment of Abdominal Obesity with Gastric Heat and Dampnes[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(12):97-102.
万红,闫诏,李媛媛等.加减消积保中颗粒联合刮痧治疗腹型肥胖胃热湿阻证的临床观察[J].中国实验方剂学杂志,2021,27(12):97-102. DOI: 10.13422/j.cnki.syfjx.20210534.
WAN Hong,YAN Zhao,LI Yuan-yuan,et al.Clinical Efficacy of Modified Xiaoji Baozhong Granules Combined with Scraping in Treatment of Abdominal Obesity with Gastric Heat and Dampnes[J].Chinese Journal of Experimental Traditional Medical Formulae,2021,27(12):97-102. DOI: 10.13422/j.cnki.syfjx.20210534.
目的
2
评价加减消积保中颗粒联合刮痧治疗腹型肥胖胃热湿阻证的疗效及对脂肪细胞因子的影响。
方法
2
将144例患者随机按数字表法分为对照组和观察组各72例。两组均进行生活方式调整。观察组给予加减消积保中颗粒+刮痧的中医综合方案,对照组给予加减消积保中模拟颗粒+刮痧。两组疗程均为3个月。比较两组患者治疗前后体质量指数(BMI),体脂率(FP),腰围(WC),腰臀比(WHR),肥胖度和腹部脂肪厚度;比较两组治疗前后空腹血糖(FBG),胰岛素抵抗指数(HOMA-IR),高密度脂蛋白(HDL),低密度脂蛋白(LDL),甘油三酯(TG),总胆固醇(TC),脂联素、瘦素、抵抗素、内脂素和肿瘤坏死因子(TNF-
α
)水平;评价临床疗效和安全性。
结果
2
治疗后观察组BMI,FP,肥胖度,WC和WHR均低于对照组(
P
<
0.01);观察组腹壁脂肪厚度和腹内脂肪厚度均低于对照组(
P
<
0.01);观察组FBG,HOMA-IR,TG,TC,LDL均低于对照组(
P
<
0.01),HDL高于对照组(
P
<
0.01);观察组脂联素高于对照组(
P
<
0.01),瘦素、抵抗素、内脂素和TNF-
α
均低于对照组(
P
<
0.01);观察组临床疗效总有效率为88.24%(60/68),高于对照组的73.53%(50/68)(
χ
2
=4.755,
P
<
0.05);
结论
2
在生活方式调整的基础上,加减消积保中颗粒联合刮痧的综合方案治疗腹型肥胖患者能减轻肥胖程度和脂肪厚度,并能调节脂、糖代谢和脂肪细胞因子,临床疗效优于单纯的刮痧疗法,且使用安全。
Objective
2
To evaluate the efficacy of modified Xiaoji Baozhong granules combined with scraping in the treatment of abdominal obesity with gastric heat and dampness syndrome and its effect on adipocytokines.
Method
2
One hundred and forty-four patients were randomly divided into the control group and the observation group, 72 cases in each group. The lifestyle adjustments were conducted in both groups. The observation group was given a comprehensive traditional Chinese medicine regimen of modified Xiaoji Baozhong granules combined with scraping. The control group was given modified Xiaoji Baozhong granules combined with scraping. The course of treatment was three months. The body mass index (BMI), body fat percentage (FP), waist circumference (WC), waist to hip ratio (WHR), obesity and abdominal fat thickness of the two groups were compared before and after treatment. The levels of fasting blood glucose (FBG), insulin resistance index (HOMA-IR), high density lipoprotein (HDL), low density lipoprotein (LDL), triglyceride (TG), total cholesterol (TC), adiponectin, leptin, resistin, endolipid and tumor necrosis factor-α (TNF-α) were compared between the two groups before and after treatment. The clinical efficacy and safety were evaluated.
Result
2
After treatment, the BMI, FP, obesity, WC and WHR of the observation group were lower than those of the control group (
P
<
0.01). After treatment, the abdominal wall fat thickness and intra-abdominal fat thickness of patients in the observation group were lower than those in the control group (
P
<
0.01). The FBG, HOMA-IR, TG, TC and LDL of the observation group were lower than those of the control group (
P
<
0.01), while the HDL level was higher than the control group (
P
<
0.01). Adiponectin in the observation group was higher than the control group after treatment (
P
<
0.01). The leptin, resistin, visfatin and TNF-α were lower than those in the control group (
P
<
0.01). The total clinical efficacy rate of patients in the observation group was 88.24% (60/68), which was better than 73.53% (50/68) in the control group (
χ
2
=4.755,
P
<
0.05).
Conclusion
2
In addition to lifestyle adjustments, modified Xiaoji Baozhong granules combined with scraping treatment can reduce the degree of obesity and fat thickness in patients with abdominal obesity, and regulate lipid, carbohydrate metabolism and adipocytokines, with a better clinical efficacy than simple scraping therapy and the safety in practice.
GORDON-LARSEN P , WANG H , POPKIN B . M. Overweight dynamics in Chinese children and adults [J]. Obes Rev , 2014 , 15 ( Suppl 1 ): 37 - 48 .
中华医学会 , 中华医学会杂志社 , 中华医学会全科医学分会 , 等 . 肥胖症基层诊疗指南(2019年) [J]. 中华全科医师杂志 , 2020 , 19 ( 2 ): 95 - 101 .
陈霞 , 黄伟 , 邓杰 , 等 . 中医治疗单纯性肥胖症的临床研究近况 [J]. 中华中医药学刊 , 2017 , 35 ( 6 ): 1454 - 1458 .
张国玉 , 燕树勋 . 从“五经”讨论腹型肥胖的病因病机 [J]. 中医临床研究 , 2020 , 12 ( 8 ): 18 - 21 .
梁坤 , 邢燕 , 陈三三 , 等 . 刮痧治疗单纯性肥胖的疗效观察 [J]. 山东中医杂志 , 2015 , 34 ( 2 ): 113 - 114 .
陈清光 , 戴正乾 , 陶枫 , 等 . 丁学屏从脾论治肥胖病临床经验 [J]. 上海中医药杂志 , 2016 , 50 ( 6 ): 17 - 19 .
危北海 , 贾葆鹏 . 单纯性肥胖病的诊断及疗效评定标准 [J]. 中国中西医结合杂志 , 1998 , 18 ( 5 ): 317 - 319 .
中华医学会内分泌学分会肥胖学组 . 中国成人肥胖症防治专家共识 [J]. 中华内分泌代谢杂志 , 2011 , 27 ( 9 ): 711 - 717 .
刘晓龙 . 成人肥胖评价方法与测量指标研究进展 [J]. 中国现代医药杂志 , 2020 , 22 ( 5 ): 105 - 108 .
黄书婷 , 杨传华 , 方丽 , 等 . 《灵枢》“三形人”分类初探 [J]. 中医杂志 , 2018 , 59 ( 8 ): 708 - 711 .
谭雁裙 , 梁桂枝 , 李丽娜 , 等 . 李红阳教授防治肥胖症的临床经验 [J]. 广西中医药 , 2018 , 41 ( 2 ): 52 - 53 .
邓爱平 , 李颖 , 吴志涛 , 等 . 苍术化学成分和药理的研究进展 [J]. 中国中药杂志 , 2016 , 41 ( 21 ): 3904 - 3913 .
顾思浩 , 孔维崧 , 张彤 , 等 . 白术的化学成分与药理作用及复方临床应用进展 [J]. 中华中医药学刊 , 2020 , 38 ( 1 ): 69 - 73 .
王玉 , 杨雪 , 夏鹏飞 , 等 . 大黄化学成分、药理作用研究进展及质量标志物的预测分析 [J]. 中草药 , 2019 , 50 ( 19 ): 4821 - 4837 .
于蓓蓓 , 闫雪生 , 孙丹丹 . 山楂药理作用及其机制研究进展 [J]. 中南药学 , 2015 , 13 ( 7 ): 745 - 748 .
李敏 , 赵振华 , 玄静 , 等 . 荷叶化学成分及其药理作用研究进展 [J]. 辽宁中医药大学学报 , 2020 , 22 ( 1 ): 135 - 138 .
KANG L L , KIM H N , JUNG Y A , et al . The effects of weight control behaviors among korean obese adults [J]. Korean J Fam Med , 2018 , 39 ( 4 ): 247 - 252 .
BEKAERT M , OUWENS D M , HÖRBELT T , et al . Reduced expression of chemerin in visceral adipose tissue associates with hepatic steatosis in obese patients [J]. Obesity (Silver Spring) , 2016 , 24 ( 12 ): 2544 - 2552 .
HOLSEN L M , JACKSON B . Reward capacity predicts leptin dynamics during laboratory-controlled eating in women as a function of body mass index: reward capacity and leptin [J]. Obesity , 2017 , 25 ( 9 ): 1564 - 1568 .
ZAYANI N , HAMDOUNI H , BOUMAIZA I , et al . Resistin polymorphims, plasma resistin levels and obesity in tunisian volunteers [J]. J Clin Lab Anal , 2018 , 32 ( 2 ): e22227 .
韩辉 , 高宏凯 . 内脂素与肥胖,2型糖尿病关系的研究进展 [J]. 武警医学 , 2016 , 27 ( 6 ): 628 - 630 .
TZANAVARI T , GIANNOGONAS P , KARALIS K P . TNF-alpha and obesity [J]. Curr Dir Autoimmun , 2010 , 11 : 145 - 56 .
0
浏览量
17
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621